Development of a concise and rapid cell-based functional assay for evaluating human Dectin-1 antagonists.

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Dectin-1 is a C-type lectin receptor crucial for antifungal immunity, inflammation, and cancer.
• Current antagonist evaluation relies on binding assays, which may not reflect functional suppression.
• There is a need for a rapid, functional, cell-based assay for human Dectin-1 (hDectin-1) antagonists.

Purpose of the Study:

• To develop and validate a rapid, functional, cell-based assay for hDectin-1 antagonists.
• To provide a more accurate method for evaluating Dectin-1 antagonist efficacy compared to binding assays.

Main Methods:

• Utilized THP-1 cells stably expressing hDectin-1 (dTHP-1 cells).
• Activated hDectin-1 with depleted Zymosan (dZymosan) to induce TNF-α production.
• Optimized assay conditions to 10 μg/mL dZymosan for 4 hours.
• Tested laminarin and Dextran T40 for inhibitory effects.

Main Results:

• The assay successfully measured dZymosan-induced TNF-α production in dTHP-1 cells.
• Laminarin demonstrated dose-dependent inhibition of TNF-α production, confirming Dectin-1 engagement.
• Dextran T40 showed no inhibitory effect, indicating assay specificity.
• The assay is concise, completing in 4 hours.

Conclusions:

• A novel, rapid (4-hour), functional, cell-based assay for hDectin-1 antagonists has been established.
• This assay directly measures physiological outcomes of Dectin-1 signaling, surpassing binding assays.
• The developed platform is valuable for screening and characterizing hDectin-1 antagonists, aiding therapeutic development for Dectin-1-related diseases.